<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03642223</url>
  </required_header>
  <id_info>
    <org_study_id>FLAB</org_study_id>
    <nct_id>NCT03642223</nct_id>
  </id_info>
  <brief_title>Central and Peripheral Adiposity and Iron Absorption</brief_title>
  <official_title>Relation Btw Adiposity, Inflammation &amp; Iron Absorption:Comparison Btw Central &amp; Peripheral Adiposity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Swiss Federal Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American University of Beirut Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Swiss Federal Institute of Technology</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adiposity is a state of sub-clinical inflammation, thus hepcidin is increased in adiposity,
      often leading to iron deficiency in this population group. Central adiposity is generally
      considered having a greater negative effect on health compared to peripheral adiposity.
      Whether this can be also seen in hepcidin and thereby in iron absorption is uncertain.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 10, 2017</start_date>
  <completion_date type="Actual">October 18, 2018</completion_date>
  <primary_completion_date type="Actual">October 18, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fractional and total iron absorption</measure>
    <time_frame>14days after the administration of the test meal</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum Hepcidin</measure>
    <time_frame>at baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum ferritin</measure>
    <time_frame>at baseline</time_frame>
    <description>iron status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum TfR</measure>
    <time_frame>at baseline</time_frame>
    <description>iron status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum CRP</measure>
    <time_frame>at baseline</time_frame>
    <description>inflammation status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum AGP</measure>
    <time_frame>at baseline</time_frame>
    <description>inflammation status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum IL-6</measure>
    <time_frame>at baseline</time_frame>
    <description>inflammation status</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">121</enrollment>
  <condition>Adiposity</condition>
  <condition>Iron-deficiency</condition>
  <arm_group>
    <arm_group_label>normal-weight</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>peripheral adiposity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>central adiposity</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stable iron isotopes</intervention_name>
    <description>Participants have to consume a test meal containing stable iron isotopes in order to determine iron absorption</description>
    <arm_group_label>central adiposity</arm_group_label>
    <arm_group_label>normal-weight</arm_group_label>
    <arm_group_label>peripheral adiposity</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  either normal-weight (BMI 18-25kg/m2) or overweight/obese (BMI 28-50kg/m2) with either
             central or peripheral fat deposits based on DEXA

        Exclusion Criteria:

          -  Iron Supplement or antibiotic intake within 2 weeks before study start

          -  diagnosed chronic disease or gastrointestinal disorders

          -  regular use of medication (except contraceptives)

          -  pregnancy

          -  lactation

          -  smoking

          -  blood donation or surgery within the last 4 months.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>American University of Beirut</name>
      <address>
        <city>Beirut</city>
        <country>Lebanon</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Lebanon</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>July 24, 2018</study_first_submitted>
  <study_first_submitted_qc>August 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2018</study_first_posted>
  <last_update_submitted>March 27, 2019</last_update_submitted>
  <last_update_submitted_qc>March 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Swiss Federal Institute of Technology</investigator_affiliation>
    <investigator_full_name>Prof. Michael B. Zimmermann</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

